Gene: ELF4
Official Full Name: E74 like ETS transcription factor 4provided by HGNC
Gene Summary: The protein encoded by this gene is a transcriptional activator that binds and activates the promoters of the CSF2, IL3, IL8, and PRF1 genes. The encoded protein is involved in natural killer cell development and function, innate immunity, and induction of cell cycle arrest in naive CD8+ cells. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Jan 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05493 | ELF4 Knockout cell line (HeLa) | Human | ELF4 | 1:3~1:6 | Negative | Online Inquiry |
KO05494 | ELF4 Knockout cell line (HCT 116) | Human | ELF4 | 1:2~1:4 | Negative | Online Inquiry |
KO05495 | ELF4 Knockout cell line (HEK293) | Human | ELF4 | 1:3~1:6 | Negative | Online Inquiry |
KO05496 | ELF4 Knockout cell line (A549) | Human | ELF4 | 1:3~1:4 | Negative | Online Inquiry |
ELF4 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to lack the ELF4 gene, a critical transcription factor involved in various cellular processes including differentiation, proliferation, and response to stimuli. These cell lines serve as valuable tools for elucidating the biological roles of ELF4 in both normal physiology and disease contexts, particularly in immune response and hematopoiesis.
The key mechanism of ELF4 Gene Knockout Cell Lines involves the precise deletion of the ELF4 gene using CRISPR-Cas9 technology. This method effectively disrupts gene function, allowing researchers to study the resultant phenotypic changes and the downstream effects on gene expression. The insights gained can lead to a deeper understanding of ELF4's pathway interactions and its overall impact on cellular behavior.
In research and clinical settings, these cell lines are essential for investigating the role of ELF4 in diseases such as leukemia and other hematological disorders. Furthermore, they provide a platform for drug screening and the development of targeted therapies by facilitating the identification of potential biomarkers and therapeutic targets associated with ELF4 expression.
Compared to other gene knockout models, ELF4 Gene Knockout Cell Lines highlight a specific niche by focusing on a transcriptional regulator with emerging relevance in multiple biological contexts. This specificity allows for more streamlined and relevant experiments, reducing the time and resources typically required to explore gene function.
The value of these cell lines to researchers and clinicians lies in their ability to simplify complex biological questions, provide reproducible results, and facilitate advancements in both academic and clinical research. Their use can help accelerate the development of therapeutic strategies and enhance our understanding of transcriptional regulation in health and disease.
Our company specializes in providing high-quality genetic tools for research applications, ensuring that our products meet rigorous scientific standards. With a commitment to innovation and excellence, we empower researchers to push the boundaries of knowledge in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.